Clinical Trial Update: Study of the Safety and Efficacy of RPH-104 in Preventing Recurrences in Patients With Idiopathic Recurrent Pericarditis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating RPH-104 to prevent recurrences in idiopathic recurrent pericarditis is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Recurrent Pericarditis

Drugs mentioned

• RPH-104

Snippet

Sponsor: R-Pharm International, LLC | Conditions: Idiopathic Recurrent Pericarditis | Phase 3 | Status: ACTIVE_NOT_RECRUITING